Temasek Life Sciences Private Limited - Net Worth and Insider Trading

Temasek Life Sciences Private Limited Net Worth

The estimated net worth of Temasek Life Sciences Private Limited is at least $2.8 Billion dollars as of 2024-06-23. Temasek Life Sciences Private Limited is the 2201 Interest of corporation controlled by you of Innovent Biologics Inc and owns about 75,712,850 shares of Innovent Biologics Inc (HKSE:01801) stock worth over $2.8 Billion. Details can be seen in Temasek Life Sciences Private Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Temasek Life Sciences Private Limited has not made any transactions after 2018-10-31 and currently still holds the listed stock(s).

Transaction Summary of Temasek Life Sciences Private Limited

To

Temasek Life Sciences Private Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Temasek Life Sciences Private Limited owns 1 companies in total, including Innovent Biologics Inc (HKSE:01801) .

Click here to see the complete history of Temasek Life Sciences Private Limited’s form 4 insider trades.

Insider Ownership Summary of Temasek Life Sciences Private Limited

Ticker Comapny Transaction Date Type of Owner
HKSE:01801 Innovent Biologics Inc 2018-10-31 2201 Interest of corporation controlled by you

Temasek Life Sciences Private Limited Latest Holdings Summary

Temasek Life Sciences Private Limited currently owns a total of 1 stock. Temasek Life Sciences Private Limited owns 75,712,850 shares of Innovent Biologics Inc (HKSE:01801) as of October 31, 2018, with a value of $2.8 Billion.

Latest Holdings of Temasek Life Sciences Private Limited

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HKSE:01801 Innovent Biologics Inc 2018-10-31 75,712,850 36.80 2,786,232,880

Holding Weightings of Temasek Life Sciences Private Limited


Temasek Life Sciences Private Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Temasek Life Sciences Private Limited has made a total of 0 transactions in Innovent Biologics Inc (HKSE:01801) over the past 5 years. The most-recent trade in Innovent Biologics Inc is the sale of 0 shares on October 31, 2018, which brought Temasek Life Sciences Private Limited around $0.

Insider Trading History of Temasek Life Sciences Private Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Temasek Life Sciences Private Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Temasek Life Sciences Private Limited Ownership Network

Ownership Network List of Temasek Life Sciences Private Limited

No Data

Ownership Network Relation of Temasek Life Sciences Private Limited

Insider Network Chart

Temasek Life Sciences Private Limited Owned Company Details

What does Innovent Biologics Inc do?

Who are the key executives at Innovent Biologics Inc?

Temasek Life Sciences Private Limited is the 2201 Interest of corporation controlled by you of Innovent Biologics Inc. Other key executives at Innovent Biologics Inc include 2502 Approved lending agent JPMorgan Chase & Co. , 2101 Beneficial owner Yu De-chao Michael , and Temasek Holdings (private) Limited .

Innovent Biologics Inc (HKSE:01801) Insider Trades Summary

Over the past 18 months, Temasek Life Sciences Private Limited made no insider transaction in Innovent Biologics Inc (HKSE:01801). Other recent insider transactions involving Innovent Biologics Inc (HKSE:01801) include a net sale of 0 shares made by Morgan Stanley , a net sale of 1,409,211 shares made by Yu De-chao Michael , and a net purchase of 485,276 shares made by The Capital Group Companies, Inc. .

In summary, during the past 3 months, insiders sold 906,250 shares of Innovent Biologics Inc (HKSE:01801) in total and bought 0 shares, with a net sale of 906,250 shares. During the past 18 months, 10,222,711 shares of Innovent Biologics Inc (HKSE:01801) were sold and 9,565,276 shares were bought by its insiders, resulting in a net sale of 657,435 shares.

Innovent Biologics Inc (HKSE:01801)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Innovent Biologics Inc Insider Transactions

No Available Data

Temasek Life Sciences Private Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Temasek Life Sciences Private Limited. Currently GuruFocus does not have mailing address information for Temasek Life Sciences Private Limited.

Discussions on Temasek Life Sciences Private Limited

No discussions yet.